Your browser doesn't support javascript.
loading
Plasma and rectal mucosal oxylipin levels during aspirin and eicosapentaenoic acid treatment in the seAFOod polyp prevention trial.
Fuller, H; Race, A D; Fenton, H; Burke, L; Downing, A; Williams, E A; Rees, C J; Brown, L C; Loadman, P M; Hull, M A.
Affiliation
  • Fuller H; Leeds Institute of Medical Research, University of Leeds, UK.
  • Race AD; Institute of Cancer Therapeutics, University of Bradford, UK.
  • Fenton H; Leeds Institute of Medical Research, University of Leeds, UK.
  • Burke L; Institute of Cancer Therapeutics, University of Bradford, UK.
  • Downing A; Leeds Institute of Medical Research, University of Leeds, UK.
  • Williams EA; Department of Oncology and Metabolism, University of Sheffield, UK.
  • Rees CJ; Population Health Science Institute, Newcastle University, UK.
  • Brown LC; MRC Clinical Trials Unit at University College, London, UK.
  • Loadman PM; Institute of Cancer Therapeutics, University of Bradford, UK.
  • Hull MA; Leeds Institute of Medical Research, University of Leeds, UK. Electronic address: M.A.Hull@leeds.ac.uk.
Article in En | MEDLINE | ID: mdl-37003144

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Aspirin / Lipoxins Type of study: Clinical_trials / Prognostic_studies Limits: Humans Language: En Journal: Prostaglandins Leukot Essent Fatty Acids Year: 2023 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Aspirin / Lipoxins Type of study: Clinical_trials / Prognostic_studies Limits: Humans Language: En Journal: Prostaglandins Leukot Essent Fatty Acids Year: 2023 Document type: Article